摘要:
Embodiments of the present disclosure pertain to ion-selective electrodes that include a metal-organic framework and an electrode surface. The metal-organic framework is associated with the electrode surface in a manner that forms an interface between the metal-organic framework and the electrode surface. Additional embodiments pertain to methods of detecting an ion in a sample by associating the sample with the ion- selective electrodes of the present disclosure. The metal-organic frameworks of the ion-selective electrodes mediate ion-to- electron transduction through the interface between the metal-organic frameworks and the electrode surface. Thereafter, the presence or absence of the ion in the sample is detected by detecting a change in potential of the ion-selective electrode and correlating the change in the potential to the presence or absence of the ion. The metal organic frameworks may simultaneously mediate ion sensing and ion-to-electron transduction through the interface between the metal-organic frameworks and the electrode surface.
摘要:
Embodiments include a device, comprising: a column line; a plurality of pixels; each pixel coupled to the column line; a comparator having an input coupled to the column line and configured to compare a signal from the column line to a threshold; and control logic coupled to the pixels and configured to selectively couple each pixel to the column line after a sampling period for each pixel.
摘要:
A method of making a plasmon-resonance biosensor includes conjugating precious metal nanorods with form factor at least 1.5 with a biological probe material. Microfluidic chambers of volume under 0.025 microliter are formed over a substrate, and an aqueous suspension of the conjugated nanorods is injected into the chambers. The nanorods are organized in rows and aligned in long dimension along the rows. The biosensor is configured to be read by obtaining an optical absorption spectrum upon exposure to the analyte. The biosensor includes precious metal nanorods organized in rows with long dimension approximately parallel to the rows. The nanorods are conjugated with biological probes capable of binding to an analyte, the probes may be an aptamer, an antibody, a protein-nucleic acid (PNA), a complimentary DNA, or an enzyme having a binding site.
摘要:
Provided herein are methods for inhibiting PCSK9, reducing PCSK9 levels, and for treating or preventing related conditions and disorders, in a subject, which includes administering to a subject an effective amount of a compound which includes derivatized cycloalkyl[i b ]indoles, e.g., cyclopenta-, cyclohexa- and cyclohepta[ b ]indoles.
摘要:
A device for detecting cotinine includes (a) a film that includes a plurality of molecularly-imprinted-polymer (MIP) coated conductive nanoparticles having specific affinity for binding with cotinine, and (b) two electrodes in contact with the film for passing electrical current through the film to detect binding with cotinine as a change in electrical conductivity of the film. A MIP coated conductive nanoparticle for detecting cotinine includes (a) a conductive nanoparticle, (b) a silicon dioxide coating formed on the conductive nanoparticle and forming a first shell around the conductive nanoparticle, and (c) an MIP coating formed on the silicon dioxide coating and forming the second shell, wherein the MIP coating includes a polymer molecularly imprinted with cotinine to provide specific affinity for binding of cotinine to the MIP coated conductive nanoparticle such that the cotinine is detectable as a change in electrical conductivity of the MIP coated conductive nanoparticle.
摘要:
A chimeric antigen receptor including a co-inhibitory receptor signaling domain, as well as a nucleic acid construct and immune cells expressing the same are described. Kits and methods of using the immune cells in the treatment or amelioration of chronic inflammation or immune-mediated autoimmunity are also provided.
摘要:
Methods for determining tumor burden, treatment toxicity and treatment efficacy using a panel of microRNAs as biomarkers in biological samples are described.
摘要:
Methods for treating breast and bladder cancer patients based upon E2F4 regulatory activity as a predictor of relapse of a patient with estrogen receptor positive breast cancer and in bladder cancer stratification are provided. This invention is a method of administering an aggressive breast cancer treatment (a) providing a ER+ breast tumor tissue sample from a patient; (b) measuring the expression of genes regulated by transcription factor E2F4 in the ER+ breast tumor tissue sample; (c) inferring changes in transcription factor E2F4 activity in the ER+ breast tumor tissue sample using the measured expression in (b); (d) comparing the inferred changes in transcription factor. E2F4 activity in the ER+ breast tumor tissue sample to transcription factor E2F4 activity in a reference sample; and (e) administering an aggressive breast cancer treatment to the patient when the ER+ breast tumor tissue sample has higher transcription factor E2F4 activity than in the reference sample.
摘要:
Methods for inhibiting the physical interaction between a guanylate cyclase a cognate effector protein or phosphodiesterase, and modulating biofilm formation are provided. The present invention provides a method for inhibiting the physical interaction between a guanylate cyclase a cognate effector protein or phosphodiesterase, and a method for modulating biofilm formation by contacting a bacterial cell expressing a guanylate cyclase and a cognate effector protein or phosphodiesterase with an effective amount of a agent that modulates the physical and specific interaction between the guanylate cyclase and cognate effector protein or phosphodiesterase. In some embodiments, the agent is a peptide or peptidomimetic.